Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleFulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 28
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT05305924 - Phase 1Taking peoplePersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 18
- Run by
- Emory University
See details and how to joinNCT06324240 - Phase 2Taking peopleGenetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
- Where
- Lebanon
- Age
- 18 years and over
- People
- 135
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT05933395 - No phaseTaking peopleFeasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 50
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07313306 - Phase 2Taking peopleCombined Immunotherapies in Metastatic ER+ Breast Cancer
- Where
- New York
- Age
- 18 years to 90 years
- People
- 102
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT04563507 - Phase 2Taking peopleTrial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
- Where
- Rochester
- Age
- 18 years and over
- People
- 22
- Run by
- University of Rochester
See details and how to joinNCT04965064 - Phase 2Taking peoplePhoton Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
- Where
- Duarte, Irvine
- Age
- 18 years and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT06910761 - Phase 2Taking peopleSequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
- Where
- Tampa
- Age
- 18 years and over
- People
- 15
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06409390 - Phase 1Taking peopleEstradiol Plus Olaparib for Breast Cancer (PHOEBE)
- Where
- Lebanon
- Age
- 18 years and over
- People
- 6
- Run by
- Mary D Chamberlin
See details and how to joinNCT05900895 - No phaseTaking peopleTargeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
- Where
- Boston, Durham, Philadelphia
- Age
- 18 years and over
- People
- 400
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06795529 - No phaseTaking peopleBiomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
- Where
- Buffalo
- Age
- 18 years and over
- People
- 700
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT04526587 - Phase 2Taking peoplePreventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
- Where
- Providence
- Age
- 18 years and over
- People
- 60
- Run by
- Brown University
See details and how to joinNCT06974604 - Phase 1/2Taking peopleA Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
- Where
- Boston, Columbus, Los Angeles, Nashville, San Antonio
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT06827613 - Phase 1Taking peopleFirst-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- Where
- Ann Arbor, Boston, Chicago, Dallas, Denver, Fairfax, Houston, Indianapolis, Madison, Nashville, New Brunswick, New Haven, New York, Orlando, Plantation, Reno, Salt Lake City, San Diego, St Louis, Tucson
- Age
- 18 years and over
- People
- 930 worldwide
- Run by
- Relay Therapeutics, Inc.
See details and how to joinNCT05216432 - Phase 1Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
- Where
- Fairfax, Houston, Omaha, Rochester, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 82
- Run by
- Biotheryx, Inc.
See details and how to joinNCT06515470 - Phase 2Taking peopleDefinitive Radiation for High-Risk Spine Metastases
- Where
- Stony Brook
- Age
- 18 years and over
- People
- 26
- Run by
- Stony Brook University
See details and how to joinNCT06165419 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
- Where
- Canton, Columbus, Springfield
- Age
- 18 years to 65 years
- People
- 657 worldwide
- Run by
- Jina Pharmaceuticals Inc.
See details and how to joinNCT03671044 - Phase 2Taking peopleStudy of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
- Where
- Louisville
- Age
- 18 years and over
- People
- 15
- Run by
- University of Louisville
See details and how to joinNCT04990921 - Phase 1Taking peopleA Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- Where
- Cincinnati, Houston, Lake Mary, Nashville, Sarasota
- Age
- 18 years and over
- People
- 112
- Run by
- Edgewood Oncology Inc.
See details and how to joinNCT04872166 - No phaseTaking peopleComprehensive Outcomes for After Cancer Health
- Where
- Boston, Columbus, Gainesville, Houston, New York, Omaha
- Age
- 18 years and over
- People
- 625
- Run by
- Pack Health
See details and how to joinNCT05349227 - Phase 1/2Not yet taking people in United StatesA Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
- Where
- Pompano Beach
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Jacinto Convit World Organization Inc.
See details and how to joinNCT06023277 - Phase 1Taking peopleAutologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- Where
- Duarte
- Age
- 18 years and over
- People
- 69
- Run by
- Minerva Biotechnologies Corporation
See details and how to joinNCT04020575